Assessment of Future Remnant Liver Function Using Hepatobiliary Scintigraphy in Patients Undergoing Major Liver Resection

Background 99m Tc-mebrofenin hepatobiliary scintigraphy (HBS) was used as a quantitative method to evaluate liver function. The aim of this study was to compare future remnant liver function assessed by 99m Tc-mebrofenin hepatobiliary scintigraphy with future remnant liver volume in the prediction o...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastrointestinal surgery Vol. 14; no. 2; pp. 369 - 378
Main Authors de Graaf, Wilmar, van Lienden, Krijn P., Dinant, Sander, Roelofs, Joris J. T. H., Busch, Olivier R. C., Gouma, Dirk J., Bennink, Roelof J., van Gulik, Thomas M.
Format Journal Article
LanguageEnglish
Published New York Springer-Verlag 01.02.2010
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background 99m Tc-mebrofenin hepatobiliary scintigraphy (HBS) was used as a quantitative method to evaluate liver function. The aim of this study was to compare future remnant liver function assessed by 99m Tc-mebrofenin hepatobiliary scintigraphy with future remnant liver volume in the prediction of liver failure after major liver resection. Methods Computed tomography (CT) volumetry and 99m Tc-mebrofenin hepatobiliary scintigraphy were performed prior to major resection in 55 high-risk patients, including 30 patients with parenchymal liver disease. Liver volume was expressed as percentage of total liver volume or as standardized future remnant liver volume. Receiver operating characteristic (ROC) curve analysis was performed to identify a cutoff value for future remnant liver function in predicting postoperative liver failure. Results Postoperative liver failure occurred in nine patients. A liver function cutoff value of 2.69%/min/m 2 was calculated by ROC curve analysis. 99m Tc-mebrofenin hepatobiliary scintigraphy demonstrated better sensitivity, specificity, and positive and negative predictive value compared to future remnant liver volume. Using 99m Tc-mebrofenin hepatobiliary scintigraphy, one cutoff value suffices in both compromised and noncompromised patients. Conclusion Preoperative 99m Tc-mebrofenin hepatobiliary scintigraphy is a valuable technique to estimate the risk of postoperative liver failure. Especially in patients with uncertain quality of the liver parenchyma, 99m Tc-mebrofenin HBS proved of more value than CT volumetry.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1091-255X
1873-4626
DOI:10.1007/s11605-009-1085-2